Name | Description | Patent Applicant | Current Assignee | Inventor | Patent Jurisdiction | Patent Number | Date of Patent | ||
---|---|---|---|---|---|---|---|---|---|
Patent 11873220 was granted and assigned to Iogen Corporation on January, 2024 by the United States Patent and Trademark Office. | 11873220 | January 16, 2024 | |||||||
Patent 11326153 was granted and assigned to Novozymes A/S on May, 2022 by the United States Patent and Trademark Office. | 11326153 | May 10, 2022 | |||||||
Patent 11384347 was granted and assigned to Novozymes A/S on July, 2022 by the United States Patent and Trademark Office. | 11384347 | July 12, 2022 | |||||||
Patent 6867031 was granted and assigned to Novozymes A/S on March, 2005 by the United States Patent and Trademark Office. | 6867031 | March 15, 2005 | |||||||
Patent 7993898 was granted and assigned to Novozymes A/S on August, 2011 by the United States Patent and Trademark Office. | 7993898 | August 9, 2011 | |||||||
Patent 11426675 was granted and assigned to Whitefox Technologies Limited on August, 2022 by the United States Patent and Trademark Office. | 11426675 | August 30, 2022 | |||||||
Patent 9108894 was granted and assigned to Iogen Corporation on August, 2015 by the United States Patent and Trademark Office. | 9108894 | August 18, 2015 | |||||||
11441134 | September 13, 2022 | ||||||||
Patent 11760630 was granted and assigned to Iogen Corporation on September, 2023 by the United States Patent and Trademark Office. | 11760630 | September 19, 2023 | |||||||
Patent 8017372 was granted and assigned to Novozymes A/S on September, 2011 by the United States Patent and Trademark Office. | 8017372 | September 13, 2011 | |||||||
Patent 10267511 was granted and assigned to BioLeap on April, 2019 by the United States Patent and Trademark Office. | 10267511 | April 23, 2019 | |||||||
11377648 | July 5, 2022 | ||||||||
Patent 10421663 was granted and assigned to Iogen Corporation on September, 2019 by the United States Patent and Trademark Office. | 10421663 | September 24, 2019 | |||||||
Patent 7160712 was granted and assigned to Novozymes A/S on January, 2007 by the United States Patent and Trademark Office. | 7160712 | January 9, 2007 | |||||||
Patent 11028378 was granted and assigned to Novozymes A/S on June, 2021 by the United States Patent and Trademark Office. | 11028378 | June 8, 2021 | |||||||
11434509 | September 6, 2022 | ||||||||
Patent 11608236 was granted and assigned to Sukup Manufacturing Co. on March, 2023 by the United States Patent and Trademark Office. | 11608236 | March 21, 2023 | |||||||
Patent 10981784 was granted and assigned to Iogen Corporation on April, 2021 by the United States Patent and Trademark Office. | 10981784 | April 20, 2021 | |||||||
Patent 7517668 was granted and assigned to Novozymes A/S on April, 2009 by the United States Patent and Trademark Office. | 7517668 | April 14, 2009 | |||||||
Patent 7163816 was granted and assigned to Novozymes A/S on January, 2007 by the United States Patent and Trademark Office. | 7163816 | January 16, 2007 | |||||||
11427811 | August 30, 2022 | ||||||||
Patent 11554119 was granted and assigned to Phibro Animal Health on January, 2023 by the United States Patent and Trademark Office. | 11554119 | January 17, 2023 | |||||||
Patent 11299686 was granted and assigned to Iogen Corporation on April, 2022 by the United States Patent and Trademark Office. | 11299686 | April 12, 2022 | |||||||
Patent 7094586 was granted and assigned to Novozymes A/S on August, 2006 by the United States Patent and Trademark Office. | 7094586 | August 22, 2006 | |||||||
Patent 7378264 was granted and assigned to Novozymes A/S on May, 2008 by the United States Patent and Trademark Office. | 7378264 | May 27, 2008 |